|
1
|
Wild S, Roglic G, Green A, Sicree R and
King H: Global prevalence of diabetes: Estimates for the year 2000
and projections for 2030. Diabetes Care. 27:1047–1053. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Alhyas L, McKay A and Majeed A: Prevalence
of type 2 diabetes in the states of the Co-operation council for
the Arab states of the Gulf: A systematic review. PLoS One.
7:e409482012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Abdul-Ghani MA and DeFronzo RA:
Pathophysiology of prediabetes. Curr Diab Rep. 9:193–199. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cavaghan MK, Ehrmann DA and Polonsky KS:
Interactions between insulin resistance and insulin secretion in
the development of glucose intolerance. J Clin Invest. 106:329–333.
2000. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Harris MI, Klein R, Welborn TA and Knuiman
MW: Onset of NIDDM occurs at least 4–7 yr before clinical
diagnosis. Diabetes Care. 15:815–825. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Thompson TJ, Engelgau MM, Hegazy M, Ali
MA, Sous ES, Badran A and Herman WH: The Onset of NIDDM and its
relationship to clinical diagnosis in Egyptian adults. Diabet Med.
13:337–340. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tuomilehto J, Lindström J, Eriksson JG,
Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S,
Laakso M, Louheranta A, Rastas M, et al: Prevention of type 2
diabetes mellitus by changes in lifestyle among subjects with
impaired glucose tolerance. N Engl J Med. 344:1343–1350. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lynn FC, Skewes-Cox P, Kosaka Y, McManus
MT, Harfe BD and German MS: MicroRNA expression is required for
pancreatic islet cell genesis in the mouse. Diabetes. 56:2938–2945.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Poy MN, Eliasson L, Krutzfeldt J, Kuwajima
S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewasky N, Rorsman P
and Soffel M: A pancreatic islet-specific microRNA regulates
insulin secretion. Nature. 432:226–230. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He A, Zhu L, Gupta N, Chang Y and Fang F:
Overexpression of micro ribonucleic acid 29, highly up-regulated in
diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes.
Mol Endocrinol. 21:2785–2794. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Plaisance V, Abderrahmani A, Perret-Menoud
V, Jacquemin P, Lemaigre F and Regazzi R: MicroRNA-9 controls the
expression of Granuphilin/Slp4 and the secretory response of
insulin-producing cells. J Biol Chem. 281:26932–26942. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tang X, Tang G and Ozcan S: Role of
microRNAs in diabetes. Biochimic Biophysic Acta. 1779:697–701.
2008. View Article : Google Scholar
|
|
14
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen X, Liang H, Zhang J, Zen K and Zhang
CY: Secreted microRNAs: A new form of intercellular communication.
Trends Cell Biol. 22:125–132. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kosaka N, Iguchi H, Yoshioka Y, Takeshita
F, Matsuki Y and Ochiya T: Secretory mechanisms and intercellular
transfer of microRNAs in living cells. J Biol Chem.
285:17442–17452. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K,
Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs
in serum: A novel class of biomarkers for diagnosis of cancer and
other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang X, Zeng Z, Hou Y, Yuan T, Gao C, Jia
W, Yi X and Liu M: MicroRNA-92a as a potential biomarker in
diagnosis of colorectal cancer: A systematic review and
meta-analysis. PLoS One. 9:e887452014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He
J, Qin YW and Jing Q: Circulating microRNA: A novel potential
biomarker for early diagnosis of acute myocardial infarction in
humans. Eur Heart J. 31:659–666. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fichtlscherer S, de Rosa S, Fox H,
Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Röxe T,
Müller-Ardogan M, et al: Circulating microRNAs in patients with
coronary artery disease. Circ Res. 107:677–684. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zampetaki A, Kiechl S, Drozdov I, Willeit
P, Mayr U, Prokopi M, Mayr A, Weger S, Oberhollenzer F, Bonora E,
et al: Plasma microRNA profiling reveals loss of endothelial
miR-126 and other microRNAs in type 2 diabetes. Circ Res.
107:810–817. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Roth P, Wischhusen J, Happold C, Chandran
PA, Hofer S, Eisele G, Weller M and Keller A: A specific miRNA
signature in the peripheral blood of glioblastoma patients. J
Neurochem. 118:449–457. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schrauder MG, Strick R, Schulz-Wendtland
R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A,
Hein A, et al: Circulating micro-RNAs as potential blood-based
markers for early stage breast cancer detection. PLoS One.
7:e297702012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Meder B, Keller A, Vogel B, Haas J,
Sedaghat-Hamedani F, Kayvanpour E, Just S, Borries A, Rudloff J,
Leidinger P, et al: MicroRNA signatures in total peripheral blood
as novel biomarkers for acute myocardial infarction. Basic Res
Cardiol. 106:13–23. 2011. View Article : Google Scholar
|
|
25
|
Keller A, Leidinger P, Bauer A, Elsharawy
A, Haas J, Backes C, Wendschlag A, Giese N, Tjaden C, Ott K, et al:
Toward the blood-borne miRNome of human diseases. Nat Methods.
8:841–843. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Alberti KG and Zimmet PZ: Definition,
diagnosis and classification of diabetes mellitus and its
complications. Part 1: Diagnosis and classification of diabetes
mellitus provisional report of a WHO consultation. Diabet Med.
15:539–553. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wong L, Lee K, Russell I and Chen C:
Endogenous controls for realtime quantitation of miRNA using
TaqMan® MicroRNA assays. Macmillan Publishers Ltd; New
York: 2007
|
|
28
|
Roggli E, Britan A, Gattesco S, Lin-Marq
N, Abderrahmani A, Meda P and Regazzi1 R: Involvement of microRNAs
in the cytotoxic effects exerted by proinflammatory cytokines on
pancreatic beta-cells. Diabetes. 59:978–986. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Poy MN, Hausser J, Trajkovski M, Braun M,
Collins S, Rorsman P, Zavolan M and Stoffel M: miR-375 maintains
normal pancreatic alpha- and beta-cell mass. Proc Natl Acad Sci
USA. 106:5813–5818. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Karolina DS, Armugam A, Tavintharan S,
Wong MT, Lim SC, Sum CF and Jeyaseelan K: MicroRNA 144 impairs
insulin signaling by inhibiting the expression of insulin receptor
substrate 1 in type 2 diabetes mellitus. PLoS One. 6:e228392011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bandi N, Zbinden S, Gugger M, Arnold M,
Kocher V, Hasan L, Kappeler A, Brunnet T and Vassella E: miR-15a
and miR-16 are implicated in cell cycle regulation in a
Rb-dependent manner and are frequently deleted or down-regulated in
non-small cell lung cancer. Cancer Res. 69:5553–5559. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cimmino A, Calin GA, Fabbri M, Iorio MV,
Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, et
al: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl
Acad Sci USA. 102:13944–13949. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sun LL, Jiang BG, Li WT, Zou JJ, Shi YQ
and Liu ZM: MicroRNA-15a positively regulates insulin synthesis by
inhibiting uncoupling protein-2 expression. Diabetes Res Clin
Pract. 91:94–100. 2011. View Article : Google Scholar
|
|
34
|
Meigs JB, Muller DC, Nathan DM, Blake DR
and Andres R: Baltimore Longitudinal Study of Aging: The natural
history of progression from normal glucose tolerance to type 2
diabetes in the Baltimore longitudinal study of aging. Diabetes.
52:1475–1484. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bock G, Dalla Man C, Campioni M,
Chittilapilly E, Basu R, Toffolo G, Cobelli C and Rizza R:
Pathogenesis of pre-diabetes: Mechanisms of fasting and
postprandial hyperglycemia in people with impaired fasting glucose
and/or impaired glucose tolerance. Diabetes. 55:3536–3549. 2006.
View Article : Google Scholar : PubMed/NCBI
|
